Rheumatoid Arthritis Clinical Trial
— JROfficial title:
Effect of Moderate to High Intensity Aerobic Interval Training on Polysomnographic Measured Sleep in Patients With Rheumatoid Arthritis. A Randomized Controlled Trial
NCT number | NCT01966835 |
Other study ID # | JR sleep |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | October 16, 2013 |
Last updated | July 17, 2014 |
Start date | May 2013 |
Poor sleep quality and sleep disturbances are common in patients with rheumatoid arthritis
and are associated with an increased risk of co-morbidity and all-cause mortality.Few
studies have examined the possibilities of improving sleep in patients with rheumatoid
arthritis, and the focus has primarily been on medical treatment. Aerobic exercise training
constitutes a potentially promising, non-pharmacological alternative to improve sleep.
This study is a randomized controlled trial of 44 patients with rheumatoid arthritis.
The aim is to investigate the effect of a moderate-to-high intensity aerobic interval
training intervention on sleep quality and sleep disturbances in patients with rheumatoid
arthritis.
The primary hypothesis is that moderate-to high intensity aerobic exercise will improve
objective measured sleep quality and sleep disturbances. The secondary hypothesis is that
the intervention may improve fitness, subjective sleep quality and physical function as well
as reduce pain, fatigue, depressive symptoms and improve health-related quality of life.
Status | Recruiting |
Enrollment | 44 |
Est. completion date | |
Est. primary completion date | December 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - age 18-70 years - a clinical diagnosis of rheumatoid arthritis - Experience poor sleep quality (PSQI >5) - Low disease activity (DAS28<3.2) - Understand Danish Exclusion Criteria: - Documented sleep apnea (AHI >15/hour) - ECG that does not allow exercise - Night work during the period in which the intervention takes place - Pregnant or are breast-feeding - Treatment with steroid, hypnotics, antidepressants, antipsychotics - Cardiac symptoms - NYHA >2 - Regular physically active (aerobic exercise >3 x per week) |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor)
Country | Name | City | State |
---|---|---|---|
Denmark | Glostrup Hospital, Copenhagen University | Glostrup | Copenhagen |
Lead Sponsor | Collaborator |
---|---|
Glostrup University Hospital, Copenhagen |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | sleep | Measured by polysomnography. Polysomnography is a objective measurement of sleep duration, sleep stages and sleep quality. | Change from baseline in objectively measured sleep to 8 weeks | Yes |
Secondary | Cardiopulmonary fitness | The patients' aerobic capacity is assessed by an incremental maximum work test on bicycle ergometer. Following a 5-minute warm-up period on individual steady state work intensity, the work load increases by 20 watt each minute until exhaustion. | change in baseline in VO2-max to 8 weeks | Yes |
Secondary | Plasma | C-reactive protein (CRP) and hemoglobin are assessed | change from baseline in plasma to 8 weeks | No |
Secondary | physiological outcomes | change from baseline in blood pressure, weight and height to 8 weeks | No | |
Secondary | Disease activity | Disease Activity Score (DAS28) is calculated from the number of swollen and tender joints (28 joints), CRP and the patients' global assessment of arthritis | change from baseline in disease activity to 8 weeks | No |
Secondary | self reported sleep quality and sleep disturbances | The Pittsburgh Sleep Quality Index (PSQI) measures self-reported sleep quality and disturbances during the previous four weeks | change from baseline in selfreported sleep to 8 weeks | No |
Secondary | self reported sleepiness | The Epworth Sleepiness Scale measures self-reported daytime sleepiness. | change from baseline in sleepiness to 8 weeks | No |
Secondary | self reported fatigue | The Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF MDQ)measures self-reported fatigue | change from baseline in fatigue to 8 weeks | No |
Secondary | self reported depressive symptoms | The Center for Epidemiological Studies-Depression (CES-D) measures self-reported depressive symptoms. | change from baseline in depressive symptoms to 8 weeks | No |
Secondary | Physical function | The Health Assessment Questionnaire (HAQ) measures self-reported physical function. | change from baseline in HAQ score to 8 weeks | No |
Secondary | self reported Health-related quality of life | EuroQol (EQ-5D-5L)measures health-related quality of life. | change from baseline in health related quality of life to 8 weeks | No |
Secondary | Health and lifestyle questionnaire | Information about self-reported comorbidity, age, gender, education, work, income, physical activity, smoking, alcohol and caffeinated drinks per day will be recorded. Patients are also asked of information about actual medical treatment. | change from baseline in health and lifestyle to 8 weeks | No |
Secondary | Sleep pattern | Patients complete sleep diaries for 14 days after each polysomnography measurement in order to closely and prospectively monitor and describe potential changes in their sleep. | change from baseline to 8 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04226131 -
MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics
|
N/A | |
Completed |
NCT04171414 -
A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT02833350 -
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
|
Phase 2 | |
Completed |
NCT04255134 -
Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
|
Phase 4 | |
Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
Completed |
NCT03248518 -
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
|
N/A | |
Completed |
NCT03514355 -
MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms
|
N/A | |
Recruiting |
NCT06005220 -
SBD121, a Synbiotic Medical Food for RA Management
|
N/A | |
Recruiting |
NCT05451615 -
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT05054920 -
Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT02037737 -
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
|
N/A | |
Recruiting |
NCT04079374 -
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
|
Phase 3 | |
Completed |
NCT02504268 -
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
|
Phase 3 | |
Recruiting |
NCT05496855 -
Remote Care in People With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Recruiting |
NCT06103773 -
A Study of Single and Multiple Oral Doses of TollB-001
|
Phase 1 | |
Recruiting |
NCT06031415 -
Study of GS-0272 in Participants With Rheumatoid Arthritis
|
Phase 1 | |
Completed |
NCT05999266 -
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
|
||
Recruiting |
NCT05302934 -
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
|
||
Recruiting |
NCT04169100 -
Novel Form of Acquired Long QT Syndrome
|
Phase 4 |